We have five factories and 23 years of experience in plant extracts

Technical Articles

We hold regular seminars and welcome inquiries if you have any questions

Let's talk

Greensky supplies standardized Ginkgo Biloba Extract (EGb 761 equivalent) with 24% flavone glycoside

2026-11-23
Related Product
Ginkgo Biloba Extract
Green Sky Bio is the largest plant extract manufacturer exporter and supplier, provide plant extract, annual production 2500 tons China
Ginkgo Biloba Extract


Table of Contents

  • What Is Ginkgo Biloba Extract and Why Is It the World's Most Studied Herbal Cognitive Enhancer?

  • Botanical Origins: The 270-Million-Year-Old Living Fossil

  • Active Compounds: Flavone Glycosides, Terpene Lactones, and Ginkgolic Acids

  • Clinical Evidence for Cognitive Function and Memory Enhancement

  • Cerebral Blood Flow and Neurovascular Protection

  • Peripheral Circulation: Tinnitus, Vertigo, and Claudication

  • Antioxidant and Anti-Inflammatory Mechanisms

  • Eye Health: Glaucoma and Diabetic Retinopathy Support

  • Quality Standards and the Ginkgolic Acid Safety Threshold

  • How to Source Premium Ginkgo Biloba Extract: A B2B Buyer's Guide

  • Applications in Supplements, Pharmaceuticals, and Functional Beverages

  • Why Choose Greensky as Your Ginkgo Biloba Extract Supplier

1. What Is Ginkgo Biloba Extract and Why Is It the World's Most Studied Herbal Cognitive Enhancer?

Ginkgo biloba, often called the "living fossil," is the sole surviving species of the Ginkgoaceae family, which existed over 270 million years ago — predating the dinosaurs. Native to China, the ginkgo tree has been cultivated in temple gardens for over a thousand years, revered in Traditional Chinese Medicine (TCM) for its medicinal properties.

Ginkgo biloba extract (GBE) is one of the most extensively researched herbal supplements in the world, with more than 3,000 peer-reviewed publications and over 400 clinical trials. In Germany and other European countries, standardized ginkgo extract (EGb 761) is a prescription medication approved for treating dementia, vertigo, tinnitus, and peripheral arterial disease.

The global ginkgo biloba extract market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2032, driven by:

  • Rising prevalence of age-related cognitive decline and dementia

  • Growing demand for natural nootropics and brain health supplements

  • Expanding applications in cardiovascular and peripheral circulation health

  • Increasing scientific validation of traditional uses

For B2B buyers, ginkgo biloba extract represents one of the most reliable herbal ingredients for building evidence-based supplement products with strong consumer recognition and repeat purchase rates.

2. Botanical Origins: The 270-Million-Year-Old Living Fossil

2.1 Botanical Profile

  • Scientific name: Ginkgo biloba L.

  • Family: Ginkgoaceae (monotypic family — only one living species)

  • Part used medicinally: Dried leaves

  • Key growing regions: China (Jiangsu, Shandong, Guangxi), France, South Carolina (USA)

  • Harvest time: Late summer to early autumn (peak flavonoid content)

2.2 Why Chinese Ginkgo Is Superior

China produces over 80% of the world's ginkgo leaf supply, and several factors contribute to the superior quality of Chinese-sourced material:

  • Climate: The temperate zones of eastern China provide optimal conditions for flavonoid and terpene lactone biosynthesis

  • Cultivation history: Centuries of selective breeding have produced high-yield, high-potency cultivars

  • Processing infrastructure: Established extraction industry with decades of optimization

  • Scale: Large-scale cultivation ensures consistent supply for industrial buyers

3. Active Compounds: Flavone Glycosides, Terpene Lactones, and Ginkgolic Acids

3.1 Primary Bioactive Constituents

Compound ClassSpecific CompoundsStandardized ContentPrimary Activity
Flavone GlycosidesQuercetin, Kaempferol, Isorhamnetin glycosides24%Antioxidant, vasodilatory, neuroprotective
Terpene LactonesGinkgolides A, B, C, J; Bilobalide6%Platelet-activating factor (PAF) antagonism, neuroprotection
Ginkgolic AcidsC13:0, C15:1, C17:1<5 ppm (safety limit)Allergenic — must be minimized

3.2 The 24/6 Standardization

The internationally recognized standard for ginkgo biloba extract is 24% flavone glycosides and 6% terpene lactones, established by the European Pharmacopoeia and adopted globally. This standardization ensures:

  • Consistent efficacy: Every batch delivers the same therapeutic dose of active compounds

  • Safety: Controlled ginkgolic acid content prevents allergic reactions

  • Regulatory compliance: Meets USP, EP, and ChP pharmacopoeial requirements

3.3 Mechanism of Action

Ginkgo biloba extract works through multiple complementary pathways:

  • PAF antagonism: Ginkgolides B and C are potent platelet-activating factor antagonists, reducing platelet aggregation and improving blood flow

  • Antioxidant cascade: Flavone glycosides scavenge free radicals and upregulate endogenous antioxidant enzymes

  • Mitochondrial protection: Bilobalide protects neurons from hypoxic damage and mitochondrial dysfunction

  • Neurotransmitter modulation: Influences cholinergic, serotonergic, and dopaminergic signaling

4. Clinical Evidence for Cognitive Function and Memory Enhancement

4.1 Dementia and Alzheimer's Disease

StudyPopulationDoseDurationKey Findings
Le Bars et al. (1997)Alzheimer's/vascular dementia (n=202)240 mg/day52 weeksSignificant cognitive improvement vs. placebo
Herrschaft et al. (2012)Dementia (n=410)240 mg/day24 weeksNon-inferior to donepezil for cognitive symptoms
Snitz et al. (2009) JAMAHealthy elderly (n=118)240 mg/day6 yearsNo prevention of cognitive decline in healthy adults

Key insight: Ginkgo biloba extract is most effective for individuals with existing cognitive impairment. The evidence for prevention in healthy adults is inconclusive, which is why product positioning should focus on "cognitive support" rather than "dementia prevention."

4.2 Mild Cognitive Impairment (MCI)

  • Meta-analysis (13 RCTs, n=1,278): Ginkgo extract significantly improved MMSE scores in MCI patients (WMD = 1.67 points)

  • Combined therapy: Ginkgo + donepezil showed superior outcomes to donepezil monotherapy in moderate Alzheimer's patients

4.3 Cognitive Performance in Healthy Adults

  • Working memory: Single doses of 120–240 mg improved working memory performance in healthy young adults

  • Attention: Improved attention and processing speed in middle-aged adults (45–65 years)

  • Mental fatigue: Reduced subjective mental fatigue during prolonged cognitive tasks

5. Cerebral Blood Flow and Neurovascular Protection

5.1 Cerebral Perfusion

Ginkgo biloba extract improves cerebral blood flow through multiple mechanisms:

  • Vasodilation: Flavone glycosides promote nitric oxide release, dilating cerebral blood vessels

  • Blood rheology: Reduced blood viscosity and improved erythrocyte deformability

  • Microcirculation: Enhanced capillary blood flow in the cerebral cortex

Imaging studies:

  • fMRI: Increased cerebral blood flow in prefrontal cortex and hippocampus

  • SPECT: Improved cerebral perfusion in patients with cognitive impairment

  • Transcranial Doppler: Increased middle cerebral artery blood velocity

5.2 Blood-Brain Barrier Protection

  • Tight junction preservation: GBE protects blood-brain barrier integrity during oxidative stress

  • Edema reduction: Bilobalide reduces cerebral edema in animal models of stroke

  • Neuroinflammation: Suppressed microglial activation and cytokine production

6. Peripheral Circulation: Tinnitus, Vertigo, and Claudication

6.1 Tinnitus and Vertigo

  • Meta-analysis (10 RCTs): Ginkgo extract significantly improved tinnitus symptoms, particularly in patients with vascular etiologies

  • Vertigo of vascular origin: Clinical trials demonstrate 40–60% improvement in vertigo symptoms with 120–240 mg/day over 6–12 weeks

  • Mechanism: Improved inner ear microcirculation through PAF antagonism and vasodilation

6.2 Intermittent Claudication

  • Meta-analysis (9 RCTs, n=686): Ginkgo extract increased pain-free walking distance by 34–76 meters compared to placebo

  • Ankle-brachial index (ABI): Modest improvement in peripheral arterial disease patients

  • Comparison: Less effective than cilostazol but better tolerated with fewer side effects

6.3 Raynaud's Phenomenon

  • RCT (n=22): 120 mg/day ginkgo extract reduced the frequency and severity of Raynaud's attacks by 56%

  • Mechanism: Vasodilation and improved peripheral microcirculation

7. Antioxidant and Anti-Inflammatory Mechanisms

7.1 Antioxidant Properties

Ginkgo biloba extract demonstrates one of the broadest antioxidant profiles among herbal medicines:

  • Free radical scavenging: Direct neutralization of superoxide, hydroxyl, and peroxyl radicals

  • Lipid peroxidation inhibition: Protects cell membranes from oxidative damage

  • Antioxidant enzyme upregulation: Increases SOD, catalase, and glutathione peroxidase activity

  • Metal chelation: Binds iron and copper ions, preventing Fenton reaction-mediated free radical generation

7.2 Anti-Inflammatory Effects

  • NF-κB inhibition: Suppresses pro-inflammatory cytokine production

  • COX-2 downregulation: Reduces prostaglandin synthesis

  • Platelet-activating factor antagonism: Ginkgolides are among the most potent natural PAF antagonists known

8. Eye Health: Glaucoma and Diabetic Retinopathy Support

8.1 Glaucoma

  • RCT (n=50): Ginkgo extract (120 mg/day for 4 weeks) improved visual field indices in patients with normal-tension glaucoma

  • Mechanism: Improved optic nerve blood flow, neuroprotection of retinal ganglion cells

  • Oxidative stress: Reduced retinal oxidative damage in animal models

8.2 Diabetic Retinopathy

  • Animal models: GBE reduced retinal vascular permeability and VEGF expression

  • Clinical observations: Improved microcirculation in the retinal vasculature

  • Combination therapy: Potential synergistic effects with lutein and zeaxanthin for comprehensive eye health

9. Quality Standards and the Ginkgolic Acid Safety Threshold

9.1 Pharmacopoeial Specifications

ParameterUSP StandardEP Standard
Flavone glycosides22–27%22–27%
Terpene lactones5.4–7.8%5.0–9.0%
Ginkgolic acids<5 ppm<5 ppm
Heavy metalsPb < 3 ppm, As < 2 ppmPb < 2 ppm, As < 1 ppm
Moisture<5.0%<5.0%
Loss on drying<5.0%<5.0%

9.2 The Ginkgolic Acid Critical Safety Issue

Ginkgolic acids are structurally similar to urushiol (the allergen in poison ivy) and can cause allergic reactions, including contact dermatitis and mucosal irritation. This is the single most important quality parameter for ginkgo extract buyers.

Premium manufacturers use specialized extraction and purification processes to reduce ginkgolic acids to <5 ppm. Low-quality extracts may contain 50–500 ppm, posing significant safety risks.

Buyer verification checklist:

  • Request HPLC test results for ginkgolic acid content

  • Verify the manufacturer uses counter-current chromatography or similar advanced purification

  • Confirm third-party testing for allergenic compounds

10. How to Source Premium Ginkgo Biloba Extract: A B2B Buyer's Guide

10.1 Key Sourcing Considerations

  • Standardization verification: Confirm 24% flavone glycosides and 6% terpene lactones via independent HPLC analysis

  • Ginkgolic acid testing: Must be <5 ppm; request COA and third-party verification

  • Solvent residues: Ensure ethanol extraction meets ICH Q3C limits

  • Heavy metals: Chinese-sourced material requires testing for Pb, As, Cd, and Hg

  • Pesticide residues: Compliant with EU maximum residue limits (MRLs)

  • Particle size and flowability: For capsule/tablet manufacturing, consistent particle size (80–120 mesh) ensures uniform filling

10.2 Supply Chain Transparency

  • Origin documentation: Ginkgo leaf should be sourced from GAP-certified cultivation areas in China

  • Batch traceability: Full documentation from harvest to finished extract

  • Stability data: Request 24-month stability studies under ICH conditions

10.3 Pricing Factors

  • Standardization level: 24/6 extract commands a premium over 24% flavone-only extracts

  • Ginkgolic acid control: Sub-5 ppm purification adds processing cost but is essential for safety

  • Certifications: ISO22000, GMP, Organic, Kosher, and Halal certifications add value

  • Order volume: Consistent annual contracts typically secure 10–20% pricing advantages

11. Applications in Supplements, Pharmaceuticals, and Functional Beverages

11.1 Dietary Supplements

  • Brain health formulas: 120–240 mg per serving (standardized 24/6), often combined with Bacopa monnieri, Phosphatidylserine, and Omega-3 DHA

  • Circulation support: Combined with Horse Chestnut, Diosmin, and Butcher's Broom for venous health

  • Eye health complexes: Paired with Lutein, Zeaxanthin, and Bilberry Extract

11.2 Pharmaceutical Applications

  • Prescription GBE: EGb 761 is approved in Germany, France, and other EU countries for dementia treatment

  • Generic formulations: Multiple generic GBE products available worldwide

11.3 Functional Beverages and Foods

  • Energy and focus drinks: Added to functional beverages targeting cognitive performance

  • Nootropic formulations: Combined with L-Theanine, caffeine, and B vitamins

12. Why Choose Greensky as Your Ginkgo Biloba Extract Supplier

Hangzhou Greensky Biological Tech.Co., Ltd delivers premium Ginkgo Biloba Extract with uncompromising quality:

  • 24% flavone glycosides / 6% terpene lactones standardization, verified by HPLC

  • Ginkgolic acids <5 ppm, well below pharmacopoeial safety limits

  • ISO22000, BRCGS, Ecocert Organic, SGS-GMP certified production facilities

  • 100,000-class clean area ensures pharmaceutical-grade manufacturing

  • Independent laboratory with HPLC, GC, and UV for comprehensive quality control

  • GAP-certified raw material sourcing from China's premier ginkgo cultivation regions

  • Full documentation package: COA, MSDS, allergen statements, and third-party testing

  • Export experience to Europe, the United States, South Korea, and Russia

Contact Greensky for specifications, samples, and competitive pricing.


TAGS:
Get a Quote